Class IIOngoingZ-1249-2025
Beckman Coulter, Inc. recalls Access Erythropoietin (EPO)
Affected lot (439363) exhibited a negative dose drop of -22% with native patient samples compared to alternate reagent lots.…
Beckman Coulter, Inc.MNMar 12, 2025
Drawn from openFDA device enforcement reports. Filter by severity, status, state, year, or manufacturer.
Showing 1–1 of 1 recalls
Affected lot (439363) exhibited a negative dose drop of -22% with native patient samples compared to alternate reagent lots.…